🏅 FDA Orphan Designation
Mycobutin
Rifabutin
Manufacturer: Adria Laboratories, Inc.
FDA-Approved Indications (2)
OBSOLETE: Mycobacterium xenopi infectionOrphan Designation
Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infections.
Rifabutin capsules are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection
Population: patients with advanced HIV infection
Indications & Usage
INDICATIONS AND USAGE Rifabutin capsules are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
💙 Support Programs
View all →Mycobutin
Adria Laboratories, Inc.
Mycobutin
Adria Laboratories, Inc.
Rifabutin
Pfizer
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.